Chemical genetics uncovers promising anti-COVID compounds

This new article publication from Acta Pharmaceutica Sinica B, discusses the identification of novel small-molecule inhibitors of SARS-CoV-2 by chemical genetics.

UK’s hearing loss organizations address misleading claims about dementia

The UK’s leading hearing loss organizations have joined forces to highlight misleading reports by some health professionals and the media that hearing loss causes dementia,

December 3, 2024

Prenatal Fentanyl Exposure Suspected in Novel Syndrome

A possible link between a novel cholesterol metabolism disorder and prenatal fentanyl exposure is under investigation. The hypothesis is that prenatal fentanyl exposure possibly interferes

December 30, 2023

Plasma pTau181 predicts Alzheimer’s progression in real-world memory clinic patients

Researchers confirm plasma pTau181 is a strong predictor for Alzheimer’s in patients with mild cognitive impairment, offering a less invasive diagnostic tool for early intervention.

September 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.